Vaxart, Inc. (NB11.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:00AM CEST
| Previous close | 0.6790 |
| Open | 0.6800 |
| Bid | 0.6905 x 0 |
| Ask | 0.8265 x 0 |
| Day's range | 0.6800 - 0.6800 |
| 52-week range | 0.5044 - 1.3300 |
| Volume | |
| Avg. volume | 395 |
| Market cap | 134.551M |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4800 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.50 |
GlobeNewswireVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that on May 17, 2024, the Compensation Committee of the Board of Directors granted inducement equity awards covering an aggregate of 22,500 shares of its common stock to one new non-executive employee to induce him to accept employment with Vaxart. The awards made are as follows: (i) an option to purchase 15,000 shares of Vaxart’s common stock, which vests as to 1
- GuruFocus.com
Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
Explore key financial outcomes, clinical trial updates, and strategic plans from Vaxart's latest earnings call.
© 2024 Yahoo. All rights reserved.